Delivery Order SPE2DX15D2205-SPE2DX24F75EA
Award Date 12/7/23
Potential Completion Date 12/8/23
Potential Value $1.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $8,765.68, was granted to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Insulin Aspart 100 unit/mL vials, ordered by the Defense Logistics Agency (DLA) Troop Support Medical from the prime contractor, Amerisourcebergen Drug Corp. The contract has a not-to-exceed ceiling value of $2,278.08 and an ultimate completion date of October 24, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a major pharmaceutical distribution firm that plays a critical role in supplying...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL vials with a 10 mL volume, valued at $1,272.60. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL pens to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $18,732.80 and is a delivery order with a firm fixed price. The ultimate completion date is January 24, 2024. There is no set-aside designation for this contract, indicating it...
- This federal contract award is for the delivery of 10 ml vials of Insulin Aspart 100 Unit/ml. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $7,692.48 and is a firm fixed price delivery order. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML to the U.S. Defense Department's Medical Supply Chain agency. The $25,835.99 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,822.60, is for the delivery of Insulin Aspart 100 Unit/ML Vials 10ML to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $2,271.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL vials. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
- This federal contract award, valued at $1,231.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of insulin aspart 100 unit/mL, a type of insulin medication, with a completion date of February 10, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/ML VL 10ML. The contract has a firm fixed price of $4,746.50 and a completion date of January 19, 2024. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical division. This IDC serves...